Roles of autophagy in cetuximab-mediated cancer therapy against EGFR

Podobne zapisy

• 1, 9-Pyrazoloanthrones Downregulate HIF-1α and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy
  od: Lu, Yang, i wsp.
  Wydane: (2010)
• The EGFR antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1α and Bcl-2 and activating the beclin-1/hVps34 complex
  od: Li, Xinqun, i wsp.
  Wydane: (2010)
• AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab
  od: Li, Xinqun, i wsp.
  Wydane: (2015)
• ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis
  od: Lu, Haiquan, i wsp.
  Wydane: (2016)
• Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α
  od: Li Xinqun, i wsp.
  Wydane: (2007-10-01)